Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00812578Phase 2Completed
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and Vitamin D deficiency (VDD) comparing Cholecalciferol with Placebo (2 arms). Primary endpoints: Insulin secretion at 12 weeks and Insulin resistance at 12 weeks. Started Dec 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00812578.